The global CRO where clinical trials run on time

Finding a CRO to deliver your pivotal Phase 2 & 3 clinical trials on time and on budget isn’t easy. Choose the CRO you can trust.

Therapeutic areas

Inflammatory Bowel Diseases (IBD)

Crohns’ Disease, Ulcerative Colitis, and other IBDs.

Oncology

Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, and other Oncology indications.

Hematology

Multiple Myeloma, Lymphomas, Leukemias, and other oncohematological indications.

Infectious Diseases

Antimicrobial and Antifungal infections and other ID.

Multiple Sclerosis

Multiple Sclerosis, Spasticity, and other neurological indications.

Rare Diseases

Hemophilia A & B, Von Willebrand Disease, Thrombocytopenia, Polycythemia Vera, Paroxysmal Nocturnal Hemoglobinuria (PNH).

Be ahead of your time.

Play Video

Our mission is to be the best CRO in the world as measured by our employees, clients, investigators, and vendors.

Our teams work tirelessly to ensure that we deliver on time and on budget. You will always know what’s going on with your study when you work with PSI. That means not losing control over study timelines and budgets.

The PSI Advantage

In 2021, PSI CRO has again received CRO Leadership Awards in five categories, including Compatibility, Expertise, Quality, Reliability, and Capabilities across two respondent groups (Overall and Small Pharma). In the Expertise category, PSI CRO is recognized as a Champion in the Leadership Awards. The CRO Leadership Awards are presented by Life Sciences Leader based on research conducted by ISR reports. The awards recognize CROs that are voted by sponsors to meet or exceed expectations.

PSI On Point

PSI has been exceedingly professional and is respected by our site as a great collaborator.

Anthony W. Tolcher, MD, FRCP, FACP